Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358320090500010018
Korean Journal of Urology
2009 Volume.50 No. 1 p.18 ~ p.22
Clinical Significance of Prostate Cancer Diagnosed by 12 Core Biopsy
Park Chans-Soo

Lee Sang-Eun
Jung Hyun
Abstract
Purpose: Twelve-core biopsy improves the detection rate of prostate cancer; however,the clinical significance of these additionally detected tumors has not been established. We retrospectively evaluated the clinical difference between prostate cancers detected by only the 12 core biopsy and by the 6 core biopsy from patients underwent radical prostatectomy.

Materials and Methods: Between February 2000 and April 2005, 124 men underwent radical prostatectomy after 12-core biopsy at Seoul National University College of Medicine, Bundang Seoul National University Hospital, Seoul National University Boramae Hospital. Among the 12-core biopsy group, we compared the subset with standard sextant cores(Group A) and the subset with lateral sextant cores(Group B). The low-risk group was defined as patients with a serum prostate-specific antigen(PSA) level less than 10.0ng/ml, a Gleason score of the final pathologic findings¡Â6, no pelvic lymph node metastasis and no lymphadenectomy performed, and a T stage¡ÂT2a.

Results: There was no statistically significant difference between low-risk patients in group A and group B(p=0.0814). Groups A and B were then divided into three groups according to preoperative PSA levels of less than 10.0ng/ml, 10.0ng/ml to less than 20.0ng/ml, and greater than 20.0ng/ml. The results of the subset analysis were the same for all three PSA categories. There was no statistically significant difference when we performed the analysis between group A and group B according to the Gleason score of the final pathologic findings and the TNM stage(p=0.0814), and there was also no statistically significant difference when we performed the analysis between group A and group B according to only the Gleason score of the final pathologic findings(p=0.5026).

Conclusions: The prostate cancers diagnosed by means of 12-core biopsy did not appear to be of a clinically lower risk than those detected with 6-core biopsy. We have firmly shown that 12-core biopsy is a more clinically effective procedure than 6-core biopsy.(Korean J Urol 2009;50:18-22)
KEYWORD
Prostatic neoplasms, Biopsy, Significance
FullTexts / Linksout information
   
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø